Correction to: npj Regenerative Medicine https://doi.org/10.1038/s41536-021-00198-0, published online 19 January 2022
In the Acknowledgements section, “This work was supported by Korean Health Technology R&D Project (NRF-2017M3A9B4061407, NRF-4792018R1C1B6008671, 2018M3A9H3020844) from the National Research Foundation of Korea as well as internal funding from iPS Bio, Inc.” should have read “This work was supported by Korean Health Technology R&D Project (NRF-2017M3A9B4061407, NRF-4792018R1C1B6008671, 2018M3A9H3020844) from the National Research Foundation of Korea.” The original article has been corrected.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Park, H.J., Han, A., Kim, J.Y. et al. Author Correction : SUPT4H1-edited stem cell therapy rescues neuronal dysfunction in a mouse model for Huntington’s disease. npj Regen Med 7, 27 (2022). https://doi.org/10.1038/s41536-022-00219-6
Published:
DOI: https://doi.org/10.1038/s41536-022-00219-6
